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Abstract
Granulomatous diseases are the heterogeneous group of the conditions of 
different etiologies with a variety of clinic syndromes and morphological features 
and nonuniform sensitivity to therapy, and the existence of granulomas as general 
dominate histological expression. Granuloma is indicative of chronic inflammation 
involving cells of the macrophage system and other inflammatory cells. After the 
antigen exposure, the activation of T-lymphocytes, macrophages, and epithelioid 
histiocytes leads to granuloma formation. Granuloma also contains the extracellular 
matrix produced by fibroblasts, which provide the boundary and isolation of anti-
gen. Their etiology may classify granulomatous diseases as infectious and noninfec-
tious. However, recent studies demonstrate that pathogenic microorganisms may 
cause the granuloma formation in diseases previously considered as noninfectious. 
In some cases, differentiation between infectious and noninfectious processes may 
be problematic. This chapter aims to highlight the multiformity of granulomatous 
diseases, characterize the pathologic features of different infectious and noninfec-
tious granulomatosis, and delineate the diagnostic approach.
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1. Introduction
Granulomatous diseases are a heterogeneous group of the conditions of various 
etiologies with a variety of clinic syndromes and morphological features, nonuni-
form sensitivity to therapy, and the existence of granulomas. Granuloma is indicative 
of chronic inflammation involving cells of the macrophage system and other inflam-
matory cells. After antigen exposure, the activation of T-lymphocytes, macrophages, 
and epithelioid histiocytes lead to granuloma formation. Granulomas also contain 
the extracellular matrix produced by fibroblasts, which provide the boundary and 
isolation of antigens. Their etiology may classify granulomatous diseases as infec-
tious and noninfectious. However, recent studies demonstrate that pathogenic micro-
organisms may cause the granuloma formation in diseases previously considered as 
noninfectious. In some cases, differentiation between infectious and noninfectious 
processes may be problematic. This chapter aims to highlight the multiple forms of 
granulomatous diseases, characterize the pathologic features of different infectious 
and noninfectious granulomatosis, and delineate the diagnostic approach.
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The term granuloma comes from the Latin word “granulum” which means 
“grain,” and the Greek suffix “"-oma” used to refer to its nodular formation. 
Granuloma is a nodular defined formation. This term designates compact cell aggre-
gates on microscopy; granulomas may consist of histiocytes and/or epithelioid cells, 
giant multinucleated cells, and other inflammatory cells (lymphocytes, neutrophils, 
and eosinophils). Epithelioid and giant multinucleated cells are monocytes/macro-
phages derivatives; the former represents good differentiated secretory cells, while 
the latter specializes in phagocytosis [1]. Giant multinucleated cells are formed by 
fusion or incomplete cell division, proven in experimental studies [2]; moreover, 
foreign-body giant cells are formed earlier, than Langhans cells. Lymphocytes are 
located mainly at the periphery of a granuloma and are represented by T-cells while 
B-lymphocytes are scattered outside the granuloma. Depending on the disease, 
T-lymphocytes are predominantly represented by T-helpers 1 and 2 or cytotoxic 
T-suppressors.
Granulomatous diseases are the heterogeneous group of the diseases of dif-
ferent etiology with a variety of clinic syndromes and morphological features, 
nonuniform sensitivity to therapy [3]. This chapter aims to highlight the variety 
of granulomatous lung diseases, to characterize the key morphological features 
of various diseases of infectious and noninfectious nature, as well as to delin-
eate the diagnostic approach. First, the granulomatous diseases, with arising 
granulomas which do not lead to necrosis development, with some exceptions are 
mentioned.
2. Sarcoidosis
Lung lesions in sarcoidosis are described in 90% of cases. The morphological 
feature of sarcoidosis is epithelioid cell granuloma, which is a compact formation of 
mononuclear phagocytes (macrophages and epithelioid cells). Each sarcoid granu-
loma has certain stages of development. These stages are as follows:
1. Early or macrophage granuloma, sometimes with a few histiocytes, lympho-
cytes, or neutrophils (Figure 1);
2. Granuloma with an epithelioid cell cluster in the center and macrophages at 
the periphery;
3. Lymphocytic epithelioid granuloma;
4. The appearance of giant multinucleated cells (at first foreign-body giant cells, 
followed by Langhans cells);
5. Early cell necrosis in the center of the granuloma due to nuclear pycnosis, the 
formation of apoptotic bodies, and epithelial cell necrosis;
6. Central fibrinoid, granular, coagulative ischemic necrosis, as a rule, in small 
foci;
7. Granuloma with fibrosis (or hyalinosis); silver stain is used to detect reticulin 
fibers;
8. Hyalinized granuloma.
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The process of granuloma organization begins at the periphery; that is why they 
have well-defined, “stamped” appearance (Figure 2).
Moreover, in sarcoidosis, granulomas of different “age” may be frequently found 
in the same samples; granulomas often form conglomerates (Figure 3) [4].
A significant number of lymphocytes in lung tissue in patients with sarcoidosis 
are predominantly represented by T-cells. It is useful to evaluate the bronchioloal-




Typical “stamped” sarcoid granuloma. H&E.
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T-helpers predominate. Giant cells in granulomas may contain cytoplasmic inclu-
sions, such as asteroid bodies, Schaumann bodies, or crystalloid structures. These 
inclusions are characteristic of sarcoidosis, but they are not pathognomonic, as they 
may be found in other granulomatous diseases [5]. The end stage of sarcoidosis is 
characterized with prominent fibrosis, sometimes with honeycombing, in which 
only the remnants of granulomas could be found (Figure 4).
Typical locations of granulomas in sarcoidosis are perilymphatic or subpleural 
zones. Granulomas in bronchi and bronchioles may be found in 15–55% cases of 
sarcoidosis. Furthermore, granulomas are often located in the vessel wall; the 
frequency of granulomatous vasculitis may reach 69% (Figure 5). In these cases, 
Figure 3. 
Multiple well-defined epithelioid cell sarcoid granulomas, forming the conglomerates. H&E.
Figure 4. 
Late-stage sarcoidosis with prominent fibrosis and remnants of granulomas. H&E.
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sarcoidosis should be differentiated from necrotizing sarcoid granulomatosis. The 
latter is attributed by some authors to the nodular form of sarcoidosis; necrosis is 
typical for this disease [6].
Summing up, sarcoidosis is characterized by sharply defined, “stamped” 
granulomas located along the lymphatic vessels with concentric fibrosis around 
the granulomas and hyalinosis inside and between the granulomas, also by granu-
lomatous vasculitis, the absence of chronic interstitial inflammation outside the 
granulomatous lesions, and the absence of organized pneumonia foci. Apart from 
sarcoidosis, a so-called nonspecific sarcoid reaction occurs in the form of epitheli-
oid cell granulomatosis. It is usually observed in regional lymph nodes, but may also 
be found in lung tissue in pseudotumors, malignant neoplasms, parasitic diseases, 
and tuberculosis. Histologically, the sarcoid reaction is characterized by its locality 
and a topical relationship with these pathological processes.
2.1 Hypersensitivity pneumonitis
The pathogenesis of hypersensitivity pneumonitis is based on type III (immu-
nocomplex) and type IV immunological reactions in the lung during allergen 
inhalation. The etiological factor of this medical condition is usually thermophilic 
bacteria, fungi, and animal proteins. Other bacteria and their products, amoeba, 
and some chemicals are much less likely to cause the disease. In case of hyper-
sensitivity pneumonitis, granulomas are poorly formed, and loose, composed of 
histiocytes, lymphocytes and, multinucleated cells; some eosinophils may also be 
identified (Figure 6) [7].
Unlike sarcoidosis, peribronchiolar localization of granulomas is typical for 
hypersensitivity pneumonitis. The triad of pathomorphological features charac-
terizes hypersensitivity pneumonitis: Nonspecific interstitial pneumonia in the 
peribronchiolar zones, non-necrotizing histiocytic (giant cell) granulomas, and foci 
of bronchiolitis obliterans. “Needle-like” inclusions are often observed inside giant 
cells in the granuloma areas and the alveoli in hypersensitivity pneumonitis. In the 
late, fibrous stage of the disease, the histological features are similar to those in 
Figure 5. 
Granulomatous vasculitis in sarcoidosis. H&E.
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usual interstitial pneumonia, only scattered giant cells or remnants of granulomas 
may be found in the fibrotic areas or in the honeycomb zones in hypersensitivity 
pneumonitis [8].
2.2 Chronic allergic disease caused by metals
Chronic berylliosis is an allergic granulomatosis. Granulomas are similar to 
those in sarcoidosis and may be slightly larger. As in sarcoidosis, granulomas have 
perilymphatic location, and lymph nodes are usually affected. The same variant 
of granulomatosis may develop as a result of zirconium exposure. The diagnosis 
should be based on the clinical history and lymphocyte transformation test [9].
2.3 Polyangiit with granulomatosis
In our opinion, of particular difficulty is the differential diagnosis of nec-
rotizing granulomatosis. Infectious disease, as one of the most common causes 
of necrotizing granulomatosis, should be differentiated from polyangiitis with 
granulomatosis (previously Wegener’s granulomatosis), aspiration pneumonia, and 
less often from nodular form of rheumatoid arthritis, necrotizing sarcoid granulo-
matosis (NSG), lung infarction, and lymphomatoid granulomatosis [10]. Despite 
the specific histological changes in these diseases, there is, however, an overlap, and 
only a combination of histological features help in the final diagnosis. Infectious 
necrotizing granuloma usually has smooth contours, commonly eosinophilic 
necrosis, surrounded by a rim of histiocytes and giant multinucleated cells. By con-
trast, in polyangiitis with granulomatosis, the necrosis zone has uneven contours 
resembling a geographical map, with a large amount of cellular debris, which gives 
the necrosis a “dirty” appearance (Figure 7).
Necrotic areas are also surrounded by a histiocytic rim; however, giant cells are 
usually few in number and are scattered without forming compact granulomas. A 
characteristic feature of polyangiitis with granulomatosis is the necrotizing vasculi-
tis with fibrinoid necrosis of the media (Figure 8);
Figure 6. 
Hypersensitivity pneumonitis: Ill-defined granuloma consisting of giant multinucleated cells with needle-like 
structures surrounded by lymphocytes, lymphocytic infiltration of interalveolar septa. H&E.
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Such vessels are observed in the inflammation; the damage to the vessel wall is 
often eccentric; also, the branches of the pulmonary arteries and veins are affected 
in this disease. The capillaritis, accompanied by intra-alveolar hemorrhages, may 
also be observed. Necrotizing vasculitis may often be found in the inflammation 
and necrosis, but this is also in the infectious granulomatosis; therefore, to con-
firm the diagnosis of polyangiitis with granulomatosis, it is necessary to carefully 
evaluate the vessels outside necrosis, and additional stains are recommended to 
identify elastic tissue (Verhoeff-van Gieson stain and others). In contrast to infec-
tious granulomatosis, lymph node involvement is not typical for polyangiitis with 
granulomatosis [11].
Figure 7. 
Polyangiit with granulomatosis: “geographic” necrosis with cell debris. H&E.
Figure 8. 
Polyangiit with granulomatosis: Fibrinoid necrosis of the vessel wall with lymphocytic infiltration. H&E.
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2.4 Allergic angiitis with granulomatosis
Necrotizing granulomatosis is also seen in (previously, Churg-Strauss syn-
drome), in combination with necrotizing vasculitis and eosinophilic pneumonia. 
Granulomas in allergic angiitis with granulomatosis are well formed; with central 
necrosis containing many eosinophils, there is also eosinophilic infiltration of the 
blood vessel walls and bronchioles, necrotizing vasculitis with eosinophils, and giant 
multinucleated cells present. However, additional clinical and laboratory data are 
necessary to determine the diagnosis, because the classical triad (granulomatosis, 
necrotizing vasculitis, and eosinophilic pneumonia) is rarely found in lungs.
2.5 Rheumatoid arthritis
Furthermore, necrotizing pulmonary granulomas may form in rheumatoid 
arthritis; however, the diagnosis in this case should be made with caution. First 
of all, one should take into account clinical data, since nodular forms of rheuma-
toid arthritis develop only in the active phase in seropositive patients with severe 
articular syndrome. As a rule, necrosis is eosinophilic, cell debris is usually located 
between the necrosis and the surrounding rim of histiocytes; it may be combined 
with vasculitis, but necrotizing vasculitis is not characteristic for this disease 
(Figure 9) [12]. The described histological features are practically indistinguishable 
from infectious granulomatosis; moreover, rare clinical cases of rheumatoid arthri-
tis and tuberculosis combination have been described, and therefore, the infection 
must be thoroughly excluded.
2.6 Necrotizing sarcoid granulomatosis (NSG)
Infectious granulomatosis should also be differentiated from NSG. Some char-
acteristics of the latter are likened to those seen in polyangiitis with granulomatosis. 
NSG is characterized by the interstitial necrosis, which is often eosinophilic, but 
Figure 9. 
Rheumatoid arthritis: Extensive necrosis with rims of histiocytes at the periphery and lymphoid infiltration of 
vessel wall. H&E.
9Pathology of Sarcoidosis and Differential Diagnostics of other Granulomatous Diseases
DOI: http://dx.doi.org/10.5772/intechopen.90693
sometimes may contain cellular debris. However, necrosis in NSG is combined with 
the non-necrotizing sarcoid-type granulomas, consisting mainly of epithelioid and 
giant multinucleated cells with just a small number of lymphocytes. These granu-
lomas tend to merge and are often located near blood vessels or in its walls, but not 
causing vasculitis (Figure 10) [6]. The following symptom triad is obligatory for the 
NSG diagnosis: sarcoid-type granulomas, granulomatous vasculitis, and necrotiz-
ing inflammation.
Since necrosis in infectious granulomatosis may be of a coagulation type, pul-
monary infarction should also be a part of the differential diagnosis. In the stage of 
organization, infarction may be surrounded by fibroblasts and inflammatory cells, 
resembling granulomatous inflammation. As a rule, in lung resection specimens 
with pulmonary infarction, thrombi can be detected in the branches of the pulmo-
nary artery that caused the development of a pulmonary infarction [13].
2.7 Granulomatous inflammation caused by infectious agents
2.7.1 Fungi
Fungi that cause deep mycoses, as a rule, do not form granulomas in the lungs. 
In most cases, fungi such as Aspergillus, Candida, and some others cause local 
mycetoma, diffuse invasive mycosis, or allergic reactions (allergic bronchopulmo-
nary aspergillosis/mycosis). The granulomatous response in these fungi infections 
is rare [14].
2.7.1.1 Histoplasmosis
Histoplasmosis is caused by H. capsulatum (North America, river valleys) and 
H. duboisii (Africa), which are budding yeast cells with a diameter of 2–4 μm. 
Microorganisms are found in the cytoplasm of macrophages, histiocytes, and 
necrotic debris. Its capsule is stained with Giemsa or PAS reaction. Both organisms 
Figure 10. 
Necrotizing sarcoid granulomatosis: Granulomatous vasculitis. H&E.
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cause the formation of epithelioid cell granulomas; however, necrotizing granulo-
matosis is more often described in H. capsulatum infection [15].
2.7.1.2 Cryptococcosis (European blastomycosis)
Cryptococcus neoformans is ubiquitous; it is found in soil and pigeon excrements. 
The fungal cell is of 4–7 μm in size, replicates by budding, and is stained with H&E, 
mucicarmin, and PAS. Cryptococci cause a spectrum of various changes in the 
lungs. A typical granulomatous reaction presents with confluent non-necrotizing 
granulomas, many multinucleated giant cells, and a mild inflammatory reaction; 
giant cells are located mainly outside the granulomas and contain cryptococcal cells 
(Figure 11).
These fungi can also be located inside necrotizing granulomas (cryptococ-
comas) resembling those with mycobacterial and other types of fungal infections 
(Figure 12). In immunocompromised individuals, cryptococcal cells are found 
inside the alveoli, in their walls, and in the interstitium, without marked inflamma-
tory reaction; some scattered multinucleated giant cells can be found [9].
2.7.1.3 Coccidiosis
Coccidia most often lead to necrotizing granuloma formation; the eosinophilic 
reaction may be marked or absent; numerous neutrophils may be observed. Like in 
other infections, granulomas are located peribronchiolar or with destroyed bron-
chioles. This process is accompanied by the formation of small non-necrotizing 
granulomas at the periphery. Coccidia are usually found in the center of necrotiz-
ing granulomas, they consist of large spherical structures (spherules) containing 
yeast-like structures (endospores). Endospores of various sizes can be located in 
necrosis or cellular debris, resembling other fungal infections. The detection of 
spherules and endospores favor the diagnosis of coccidiosis. Like Histoplasma, 
Coccidia do not grow in vitro; thus, the diagnosis can only be made by histological 
examination [15].
Figure 11. 
Cryptococci cells and multinucleated giant cells in a granuloma. Combined stain of alcian blue and PAS.
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2.7.1.4 Blastomycosis
Blastomycosis is a rare disease, and this diagnosis may be suspected when 
granulomatosis or giant cell lesion in combination with severe acute inflamma-
tion is detected. Blastomycosis is characterized by basophilic necrosis rich in 
cellular debris in contrast to eosinophilic or slightly “dirty” infectious necrotizing 
granulomas. Blastomycosis is often a bronchiolocentric process. Large, thick-
walled, yeast-like Blastomyces cells can be detected in H&E and also mucicarmin 
staining. Active budding is a distinctive feature of the microorganism; nuclear 
material (multiple nucleoli) can also be found inside the cells, but these signs are 
not always observed. In this regard, compared to Histoplasma and Cryptococci cells 
and coccidial endospores, Blastomyces cells are larger but still smaller than coccidial 
spherules [15].
2.7.1.5 Pneumocystosis
Most pathologists are familiar with the conventional picture of pneumonia 
caused by Pneumocystis, but 5–17% describe the formation of an ill-defined 
intraalveolar epithelioid or histiocytic granuloma around the eosinophilic exudate, 
sometimes without exudate; the formation of well-defined granulomas with central 
necrosis or without it is also possible [16, 17]. Sometimes the granulomatous reac-
tion in pneumocystis pneumonia is a foreign-body granulomatosis (Figure 13).
2.8 Parasites
Dirofilaria is one of the most common parasites that lead to the granulomatous 
inflammation in lungs. This nematode infects dogs more commonly, but the disease 
can also occur in humans, as the infection is transmitted through an insect bite; 
the larva enters the right heart and into the pulmonary arteries during embo-
lism, causing thrombosis of the latter with an infarct-like necrosis development 
(Figure 14). In one-third of the cases, granulomas are formed in the adjacent lung 
Figure 12. 
Necrotizing granuloma fragment with cryptococci cells. H&E.
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tissue, necrotizing or non-necrotizing vasculitis is observed in half of the cases, and 
two-thirds of the cases demonstrate eosinophilic infiltration [18].
2.9 Tuberculosis
Tuberculosis is caused by members of the Mycobacterium tuberculosis family, 
namely, M. tuberculosis, M. bovis, and M. africanum, which belong to the group of 
rapidly growing mycobacteria. The virulence of these microorganisms varies from 
moderate to highly virulent strains. Changes observed in the lungs in tuberculosis 
patients can be very diverse ranging from common necrotizing granulomas, miliary 
necrotizing granulomas to non-necrotizing granulomas, tuberculoma, and healed 
Figure 13. 
Perivascular foreign-body granuloma (talcosis) in a case of pneucystic pneumonia in a drug abuser. H&E in 
bright field versus polarization.
Figure 14. 
Dirofilaria larva in the pulmonary artery, infiltration of plasma cells and eosinophils. H&E.
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fibrosus granulomas, all of these depend on the virulence on the one hand and the 
immune defense status on the other (Figure 15) [19]. Granulomas in tuberculosis 
usually have a bronchiolocentric localization, but it should be kept in mind that 
this could be the case in any infectious granulomatosis and even in sarcoidosis. 
Histological features in tuberculosis are indistinguishable from those in non-
tuberculous granulomatosis. This was confirmed in a study by Corpe and Stergus, 
in which 27 pathologists, specializing in the mycobacterial disease diagnostics, were 
asked to evaluate 25 histological slides without information about culture-con-
firmed infection. In most cases, it was not possible to distinguish between tubercu-
losis and mycobacteriosis [20]. Thus, the tuberculosis diagnosis should be based on 
the identification and subsequent determination of the type of Mycobacterium.
2.10 Non-tuberculosis mycobacteriosis
Non-tuberculosis mycobacteriosis is an inflammation caused by mycobacteria 
not belonging to the Mycobacterium tuberculosis family; those are M. avium, M. 
fortuitum, M. gordonae, M. kansasii, M. xenopi, and M. marinum, also designated 
as MAC complex. Unlike Mycobacterium tuberculosis, these mycobacteria can be 
detected intracellularly in macrophages (histiocytes), and they can be numerous in 
immunocompromised individuals. The diagnosis is made based on acid-fast stain, 
cultural or molecular biological tests. As mentioned above, the histological changes 
are often similar to those in tuberculosis. Non-necrotizing granulomas, histiocytic 
granulomas, and granulomas consisting of foamy and granular macrophages 
containing mycobacteria can also be detected. Solovieva et al. have described the 
following spectrum of histological changes in mycobacteriosis:
• tuberculous granuloma—epithelioid cell tissue, variable number of Langhans 
cells and the necrosis intensity, few mycobacteria;
• a reactive, necrotizing multibacillarity—weak inflammatory response, abun-
dance of mycobacteria in the necrosis area;
Figure 15. 
Tuberculous necrotizing granuloma with lymphocytes, histiocytes, and giant multinucleated Langhans at the 
periphery. H&E.
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• multibacillary histiocytosis—diffuse macrophage infiltration with an intracel-
lular abundance of mycobacteria, no necrosis;
• multibacillary minimal histiocytosis—a mild inflammatory reaction with an 
intracellular abundance of mycobacteria;
• histoid lesion—nodular clusters of spindle-shaped macrophages with an 
abundance of mycobacteria;
• nonspecific granulation tissue;
• acute purulent abscess [21].
The MAC-hypersensitivity-like disease has also been described (or “hot tub 
lung”); it is caused by mycobacteria of the MAC complex, and associated with the 
use of sauna and showers, which leads to the aerosol inhalation. The histological 
features of this disease are similar to the hypersensitivity pneumonitis changes [22].
2.11 Differential diagnostics of granulomatous lung diseases
A variety of diseases leading to granulomatosis determine certain difficulties 
in conducting the differential diagnostics even when resectional (surgical, video-
assisted) biopsies are performed, which allows obtaining a sufficient amount 
of material for histological evaluation [23]. However, it is not always possible to 
establish the cause of granulomatous inflammation. According to Ulbright and 
Katzenstein, who analyzed 86 solitary lung granulomas detected by X-ray, the 
infection caused by acid-resistant mycobacteria or fungi was confirmed in 70%. In 
25 cases, the infectious etiology was not proven, while two patients were diagnosed 
with hyalinized granuloma, one patient—with polyangiitis with granulomatosis, 
and in 22 cases, it was not possible to classify the process. Also, a significant similar-
ity of histological changes in infectious granulomas and polyangiitis with granulo-
matosis was found; it may be possible that the latter was a reflection of the immune 
response disorders to an infectious agent which could no longer be found in the 
tissue samples. This means that polyangiitis with granulomatosis and other lung 
angiitis diagnoses should be made with extreme caution in cases with solitary nodes 
while no damage to other organs is detected. In such cases, a thorough examination 
of patients and follow-up should be recommended [24].
Mukhopadhyay et al. conducted a multicenter retrospective study of 500 
biopsies from 10 clinics in the United States, Britain, Austria, Brazil, Japan, Turkey, 
and India with pulmonary granulomatosis. During the biopsy analysis, a specific 
diagnosis was established in 58% of the cases: most commonly sarcoidosis (27%) 
and mycobacterial infection (25%) were detected. Mycobacterial infection was 
proved in 18% outside the USA versus 8% in the USA; on the contrary, fungal 
infection amounted to 19% in the USA (most often histoplasmosis) versus 4% in 
other countries. Fungi were commonly detected by histological examination, while 
mycobacterial infection was confirmed in culture. In 42% of the cases, the etiologi-
cal factor of granulomatosis was not established.
This study, in our opinion, is extremely interesting: First of all, it indicates the 
predominance of sarcoidosis and infectious granulomatous inflammation in the 
structure of granulomatous diseases according to histological analysis conducted in 
different countries and geographical regions. Fungal infection more often caused 
granulomatous inflammation in the United States, while mycobacterial infection 
was more often diagnosed in other countries, which is a reflection of the infection 
15
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endemicity. It is crucial to send the specimen simultaneously to the histological and 
microbiological laboratory in all cases when a granulomatous disease is suspected, 
that will definitely improve the quality of the etiological diagnosis. According to 
this study, the cause of granulomatosis was not established in more than a third of 
clinical cases even after histological examination [22].
The frequency of infectious granulomatosis is high. When all other causes based 
on the clinical history, clinical syndromes, laboratory tests, and specific morpholog-
ical features mentioned above are excluded, the remaining granulomatous diseases 
are most likely to be attributed to infectious.
An important issue in the differential diagnosis of the infectious granulomatosis 
diseases is the detection of an infectious agent in microscopical slides. To achieve 
this, it is necessary and obligatory to perform additional stains. One can detect 
fungal infection, first of all, by carefully evaluating hematoxylin- and eosin-stained 
(H&E) slides. Most fungi, such as Cryptococcus, Blastomyces, Cocidioides, and 
Aspergillus, can be found in H&E slides, more often in necrosis areas than in the 
adjacent lung tissue. The pathologist should select slides with necrosis present when 
ordering additional stains. Grocott’s methenamine silver stain and the PAS reaction 
are the most commonly used for the fungal infection diagnosis confirmation, also 
alcian blue (Mouri), the basic brown stains (Shubich’s method), or the combined 
stain of PAS with alcian blue [14].
Ziehl-Neelsen stain is used to diagnose mycobacterial infection; however, mycobac-
teria are usually few in number, and their search is quite time-consuming. Alternative 
stains with auramine or auramine/rhodamine increase the sensitivity of the method, 
but these techniques require fluorescence microscopy (Figure 16a and b). To increase 
the detection of mycobacteria, Ulbright and Katzenstein recommend performing 
staining in at least two blocks [24]. Gomori silver or Warthin-Starry stains are recom-
mended for syphilis diagnosis [9].
One of the open questions is whether there are additional opportunities, mod-
ern techniques for diagnosing infectious granulomatosis. Immunohistochemistry 
is available, but it has several limitations, namely cross-reactivity, as well as the 
antibody accessibility, especially for rare microorganisms. In situ hybridization may 
Figure 16. 
Acid-fast mycobacteria: (a) Ziehl-Neelsen stain and (b) auramine/rhodamine (fluorescence).
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also be useful, but not for the detection, but for the identification of fungi found in 
traditionally stained slides. Real-time PCR can be performed on paraffin sections 
for tuberculosis diagnostics; the specificity of this method is 99%; however, the 
sensitivity amounts to only 65%. Nevertheless, when the same method is used to 
detect mycobacteria tuberculosis in the cerebrospinal fluid, urine, or bronchoal-
veolar lavage, the sensitivity is more than 90%. Thus, this technique is useful and 
confirms the diagnosis if mycobacteria are detected, but PCR does not exclude the 
tuberculosis diagnosis if the result is negative. In addition, it does not allow detect-
ing non-tuberculous mycobacteria. According to Aubry, the cultural study remains 
the “gold standard” for non-tuberculous mycobacteriosis diagnostics, and, accord-
ing to their research, indicates that in more than 75% of cases, the only method to 
confirm mycobacteriosis was in culture [10].
The etiological factor remains unclear in 30–40% of infectious granulomatosis 
even in leading US university clinics despite a complete histological evaluation of 
lung tissue slides, as well as correlations with clinical, microbiological, and serologi-
cal data. In this regard, the question of diagnostic significance of these diseases 
arises. Ulbright and Katzenstein propose that such cases represent infectious 
granulomas in which the microorganism was destroyed and/or removed by means 
of the developed inflammatory process [24]. A retrospective analysis of necrotizing 
granulomas showed that patients who did not receive further specific therapy were 
still alive and did not demonstrate any clinical symptoms. The same hypothesis is 
confirmed by Aubry who notes that even if new foci appear in these patients, poor 
outcomes were not detected [10]. It can be recommended to pathologists to give 
a descriptive histological conclusion indicating the presence/absence of necrosis, 
the absence of detected microorganisms: “The disease etiology is most likely to be 
infectious, special stains for the microorganism detection are negative.”
When a granulomatous disease is suspected and lung resection is performed, it 
is necessary to save some specimen tissue unfixed for possible cultural study, and 
use the quick freeze method at -70°С for subsequent DNA and RNA analyses, if 
available. In the differential diagnosis of granulomatous diseases, first of all, one 
should determine whether the granuloma is infectious, or there are signs of other 
diseases, including Wegener’s granulomatosis. If a specific diagnosis is excluded, 
it is crucial to perform special stains for microorganism detection, it is preferable 
to stain sections from at least two blocks, while making sure that necrosis foci are 
present in the material. If the microorganism detection is not possible at the first 
glance, we recommend evaluating the slides again at a higher magnification, and 
also using an additional block for staining. When negative result is received, but 
clinical data are in favor of tuberculosis or other infections, PCR is suggested. 
Additional cultural and serological studies, which would be able to exclude the 
infectious process, should be performed in case of another negative result obtained. 
Nevertheless, according to this algorithm results, a certain part of granulomatous 
diseases appears to have an uncertain etiology.
In conclusion, we would like to emphasize that the differential diagnosis of gran-
ulomatous pulmonary diseases is not so easy for pathologists. To exclude or prove 
the infectious disease, the pathologist should carefully examinate special stained 
specimens. Noninfectious granulomatous lung disease should be proved, taking 
into consideration both clinical and radiological data. Finally, from the pathologic 
point of view, there are the situations for which a specific diagnosis cannot be made. 
Multidisciplinary approach sometimes is recommended for decision-making.
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